The Chronic Kidney Disease (#ckd) Drugs Market is no longer just about managementโit's about preservation. ๐งฌ
With a projected value of $22.56B by 2032, the shift toward SGLT2s, GLP-1s, and "Smart Dosing" is transforming renal care. The future? Early intervention. ๐ฉบ๐ป
Source @ https://www.maximizemarketrese....arch.com/market-repo
#healthtech #pharma #nephrology #markettrends
ืชืืืื
ืึทืึฒืืึนืง
